MacroGenics Inc.

NASDAQ: MGNX · Real-Time Price · USD
1.57
-0.05 (-3.09%)
At close: Aug 15, 2025, 3:59 PM
1.56
-0.64%
After-hours: Aug 15, 2025, 05:39 PM EDT

MacroGenics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
148.34M 57.19M 151.94M 75.64M
Cost of Revenue
12.3M 8.22M 7.38M 2.65M
Gross Profit
136.04M 48.97M 144.56M 72.99M
Operating Income
-110.58M -168.24M -121.42M -202.79M
Interest Income
9.42M 9.69M 1.7M 2M
Pretax Income
-66.02M -9.06M -119.76M -202.12M
Net Income
-66.97M -9.06M -120.02M -190.86M
Selling & General & Admin
71.05M 52.19M 58.95M 63.01M
Research & Development
177.19M 166.58M 207.03M 214.58M
Other Expenses
-1.62M -1.56M 1.66M -1.8M
Operating Expenses
246.62M 217.22M 265.98M 275.79M
Interest Expense
1.11M 1.43M 263K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
258.92M 225.44M 273.36M 278.44M
Income Tax Expense
944K n/a 263K -11.26M
Shares Outstanding (Basic)
62.62M 61.93M 61.41M 59.94M
Shares Outstanding (Diluted)
62.62M 61.93M 61.43M 59.94M
EPS (Basic)
-1.07 -0.15 -1.95 -3.18
EPS (Diluted)
-1.07 -0.15 -1.95 -3.18
EBITDA
-57.37M 2.02M -107.89M -190.86M
EBIT
-64.91M -7.63M -119.76M -202.12M
Depreciation & Amortization
7.54M 9.64M 11.87M 11.26M